Mesenchymal stem cell therapy for recessive dystrophic epidermolysis bullosa: prospects and clinical progress

E. Rashidghamat; J. E. Mellerio; A. E. Martinez; J. A. McGrath

doi:10.1517/21678707.2016.1152886

Mesenchymal stem cell therapy for recessive dystrophic epidermolysis bullosa: prospects and clinical progress

E. Rashidghamat, J. E. Mellerio, A. E. Martinez, J. A. McGrath^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	343-345
Number of pages	3
Journal	Expert opinion on orphan drugs
Volume	4
Issue number	4
Early online date	19 Feb 2016
DOIs	https://doi.org/10.1517/21678707.2016.1152886
Publication status	E-pub ahead of print - 19 Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1517/21678707.2016.1152886

Cite this

@article{f72f617539544d9f9c90c4229144f957,

title = "Mesenchymal stem cell therapy for recessive dystrophic epidermolysis bullosa: prospects and clinical progress",

author = "E. Rashidghamat and Mellerio, {J. E.} and Martinez, {A. E.} and McGrath, {J. A.}",

year = "2016",

month = feb,

day = "19",

doi = "10.1517/21678707.2016.1152886",

language = "English",

volume = "4",

pages = "343--345",

journal = "Expert opinion on orphan drugs",

issn = "2167-8707",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Mesenchymal stem cell therapy for recessive dystrophic epidermolysis bullosa

T2 - prospects and clinical progress

AU - Rashidghamat, E.

AU - Mellerio, J. E.

AU - Martinez, A. E.

AU - McGrath, J. A.

PY - 2016/2/19

Y1 - 2016/2/19

UR - http://www.scopus.com/inward/record.url?scp=84961208563&partnerID=8YFLogxK

U2 - 10.1517/21678707.2016.1152886

DO - 10.1517/21678707.2016.1152886

M3 - Article

AN - SCOPUS:84961208563

SN - 2167-8707

VL - 4

SP - 343

EP - 345

JO - Expert opinion on orphan drugs

JF - Expert opinion on orphan drugs

IS - 4

ER -

Mesenchymal stem cell therapy for recessive dystrophic epidermolysis bullosa: prospects and clinical progress

UN SDGs

Access to Document

Other files and links

Cite this